Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products
To order this 750+ page report, which features 200+ figures and 250+ tables, please visit this link
The USD 13.9 billion (by 2030) financial opportunity within the biopharmaceutical manufacturing market has been analyzed across the following segments:
- Commonly Outsourced Business Operations
- Active Pharmaceutical Ingredients (API)
- Finished Dosage Formulations (FDF)
- Types of Expression System
- Mammalian
- Microbial
- Others
- Company Size
- Small
- Mid-Sized
- Large and Very Large
- Scale of Operation
- Preclinical
- Clinical
- Commercial
- Key Geographical Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
The Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030. report features the following companies, which we identified to be key players in this domain:
- 3P Biopharmaceuticals
- Abzena
- Albany Molecular Research
- BioVectra
- BioXcellence (Boehringer Ingelheim)
- Celonic
- Charles River Laboratories
- ChemPartner
- Cobra Biologics
- CordenPharma
- Cytovance Biologics
- GE Healthcare
- Goodwin Biotechnology
- Grand River Aseptic Manufacturing
- IDT Biologika
- KBI BioPharma
- Kemwell Biopharma
- LFB Biomanufacturing
- Meridian Life Science
- Patheon
- Pfizer CentreOne
- PX'Therapeutics
- Samsung BioLogics
- Sanofi, CEPiA
- Thermo Fisher Scientific
- Vetter Pharma International
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Competitive Landscape
5. Biopharmaceutical Contract Manufacturing in North America
6. Biopharmaceutical Contract Manufacturing in Europe
7. Biopharmaceutical Contract Manufacturing in Asia Pacific And the Rest of The World
8. Biopharmaceutical Contract Manufacturing in Asia Pacific And the Rest of The World
9. Case Study: Outsourcing of Biosimilars
10. Case Study: Comparison of Small Molecule and Large Molecule Drugs / Therapies
11. Case Study on In-House Manufacturing
12. Collaborations
13. Recent Developments
14. Capacity Analysis
15. Demand Analysis
16. Market Forecast
17. SWOT Analysis
18. Future of The Biopharmaceutical CMO Market
19. Survey Analysis
20. Interview Transcripts
21. Appendix 1: List of Non-Industry Players
22. Appendix 1: List of Non-Industry Players
23. Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415